Sherbrooke Park Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,971
Closed -$799K 715
2025
Q2
$799K Buy
+1,971
New +$824K 0.35% 71
2024
Q1
Sell
-562
Closed -$298K 997
2023
Q4
$298K Buy
+562
New +$272K 0.14% 259
2023
Q3
Sell
-1,400
Closed -$730K 616
2023
Q2
$730K Buy
+1,400
New +$755K 0.38% 83

Other funds holding TMO

Sherbrooke Park Advisers's TMO Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 1,971 shares — an estimated $799K sold.

Sherbrooke Park Advisers first reported a position in TMO in Q2 2023 and held it in 3 quarters. The position peaked at $799K in Q2 2025. 2,510 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,971 Thermo Fisher Scientific shares in Q3 2025, an estimated $799K.
  • Sherbrooke Park Advisers first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Thermo Fisher Scientific position peaked at $799K in Q2 2025.
  • 2,510 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.